REFERENCES
- Baldessarini R J, Tondo L, Strombom I M, et al. Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry 2007; 15: 133–45
- Isacsson G, Bergman U, Rich C L. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996; 41: 1–8
- Hall W D, Mant A, Mitchell P B, Rendle V A, Hickie I B, McManus P. Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ 2003; 326: 1008–12
- Isacsson G. Suicide prevention—a medical breakthrough?. Acta Psychiatr Scand 2000; 102: 113–7
- Ludwig J, Marcotte D E. Anti-depressants, suicide, and drug regulation. J Policy Anal Manage 2005; 24: 249–72
- World Health Organization. 2007, At http://www.who.int/mental_health/prevention/suicide/country_reports/en/index.html Country reports and charts available [on suicide]
- U.S. Centers for Disease Control and Prevention, At http://webapp.cdc.gov/sasweb/ncipc/leadcaus10.html WISQARS Leading Causes of Death Reports. 2008
- Gibbons R D, Brown C H, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164: 1356–63
- Libby A M, Brent D A, Morrato E H, Orton H D, Allen R, Valuck R J. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007; 164: 884–91
- Valuck R J, Libby A M, Orton H D, Morrato E H, Allen R, Baldessarini R J. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry 2007; 164: 1198–205
- Laughren T P. Overview for a meeting of the Psychopharmacology Drug Advisory Committee (PDAC) concerning suicidal risk in trials of antidepressant drugs in juvenile and adult patients. 2006, At http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-index.htm